Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Top Supplement Stories 2013: POM Saga, Spiked Products, GMPs

This article was originally published in The Tan Sheet

Executive Summary

Experts’ predictions for tighter GMP enforcement and the federal government shutdown’s effect on industries regulated by CFSAN joined the POM-FTC litigation and Pfizer’s work to identify bad actors making ED-spiked supplements as top supplement sector stories in “The Tan Sheet” during 2013.


Related Content

FDA Shutdown Lands Hard On CFSAN-Regulated Industries
Trade Groups, Emord Rip FTC Interpretation Of POM Wonderful Ads
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
Pfizer Guards Viagra Sales, Moves Against Tainted Supplements
Probiotic Claims Hit Regulatory Wall, But Media Gives An Advertising Lift
Probiotics Industry Says FDA Regulatory Bar Is Set Too High
Food Safety User Fees On Hold Until FDA Creates Waiver Process


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts